If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Find us on

Top 20 Drugs in the World 2017

The global prescription drug market is expected to grow by 6% from 2016 to 2022...

Numéro 1 Suisse, Numéro 2 européenne : l’UNIGE surclasse en innovation

La revue Nature publie cette année un Nature Index Innovation, dans lequel l’Université de Genève...

Un groupe américain rachète la start-up vaudoise KB Medical

La société lausannoise KB Medical, qui développe une solution d’assistance robotique pour les chirurgiens, a...

Neuromodulation of Neural Microcircuits NM2 Conference @ Campus Biotech

The Blue Brain Project will be hosting a three-day conference, “Neuromodulation of Neural Microcircuits NM²”...

La biotech bâloise Roivant lève plus d’un milliard de dollars

Etablie à Bâle depuis décembre dernier, cette start-up d’origine américaine voit son modèle d’affaires original...

Les étapes du cycle de vie d’un médicament en expo

“De la molécule à la pilule” est une exposition de l’Ecole des sciences pharmaceutiques de...

Changement de cap opérationnel pour Neode

Le parc technologique et industriel neuchâtelois, Neode, présent sur les sites de Neuchâtel et La...

Les hôpitaux balaient le plan de Berset

La faîtière des établissements hospitaliers estime que le modèle présenté mercredi par le Conseiller fédéral...

Le nouveau système des franchises passe mal

Le nouveau système de rabais pour les franchises à option dans l’assurance maladie passe mal....

Les psychotropes sous contrôles

Trop de patients manquent de renseignements, selon Pro Mente Sana qui publie une brochure d’informations...

Welcome To Health Valley

Building on skills honed over the centuries, western Switzerland has become a world leader in biotech.

Biopôle announces StartLab, tailor-made Incubator for Life Sciences Entrepreneurs

Biopôle SA, a leading Swiss life sciences park, today announced the creation of StartLab, the first incubator dedicated to life sciences located in the Canton of Vaud.

Apidel SA announces R&D collaboration with DNDi in the field of neglected diseases

Apidel announces the signature of an agreement to collaborate with DNDi on the preclinical development of a topical treatment for Cutaneous Leishmaniasis, a neglected disease affecting between 0.7 to 1.2 million people worldwide. A promising drug candidate will be tested with Apidel’s proprietary drug delivery technology ApidSOL™.

Merck KGaA, Darmstadt, Germany Licenses Selexis SUREtechnology Platform for Immuno-Oncology Antibody

Geneva, Switzerland, 30 MAY 2017 – Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today that it has entered an agreement with an affiliate of Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, to leverage the Selexis SUREtechnology Platform™ and SURE CHO-M (suspension-adapted CHO-K1) cell line to advance a Merck KGaA, Darmstadt, Germany immuno-oncology antibody program.

Selexis SA and OSE Immunotherapeutics Sign Commercial License Agreement to Further Advance Developme

Selexis SA and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announced today the signing of a commercial license agreement that provides OSE Immunotherapeutics with access to high performance research cell banks (RCBs) from the Selexis SUREtechnology Platform™. The agreement builds upon previous collaboration between the two companies as announced in November 2016 and is designed to support the advancement of the clinical development of OSE’s interleukin receptor 7 antagonist, OSE-127 (Effi-7), under development as a potential treatment for inflammatory bowel diseases, such as ulcerative colitis.
Archive:  2017  2016  2015  2014  2013  2012  2011  2010 
Find an actor

4à6 de BioAlps - Selexis SA20.09.2017

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

Welcome To Health Valley

Building on skills honed over the centuries, western Switzerland has become a world leader in biotech.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn